Come Join us in Sunny Hilton Head
Featuring Keynote Speaker: Dr Carlos DeCastro
Distinguished hematologist-oncologist Dr. DeCastro’s career has been marked by a fervent commitment to excellence, compassion, and groundbreaking research. He will share his innovative approach to deepen the understanding of PNH as a paradigm for rare diseases.
Don’t miss this opportunity to gain valuable insight into the future of treating challenging blood disorders.
DDHM 2025 brings together national experts in the field of hematologic malignancies to debate and discuss advancements in these cancers, emerging research, and current treatment paradigms. This unique and engaging format provides the opportunity for clinicians to consider expert opinion, review comprehensive research, and apply the latest information through roundtable discussions, case studies, and debates.
Networking Opportunities:
Connect with national experts at our Oceanside Reception each evening
Debate Topics:
Amyloidosis, Follicular Lymphoma, CLL novel combinations, racial disparities in AML, DLBCL, and a wide range of hematologic malignancy debates.
Clinical Quandaries Case Discussion:
Do you have a unique or unusually challenging hematologic malignancy patient with atypical symptoms, challenging co-morbidities, or has failed multiple lines of treatment? Clinical Quandaries Panel, provides an exciting opportunity to have Duke Debate Speakers working in the field of hematologic malignancy discuss, review, and provide real world advice on the management of your own challenging hematologic malignancy. Submit cases to : Tracy.torgerson@duke.edu
Nationally Recognized Speakers:
Dr Lindsey Rein, Dr Ann-Kathrin Eisfeld, Dr Adetola Kassim, Dr Mathew Lunning, Dr Jie Wang, Dr. Mathew McKinney, Dr. Danielle Brander, Dr. Jonathan Friedberg, Dr Debbie Stephens, Dr Andrea Sitlinger, Dr Tae Choi, Dr Yubin Kang, Dr. Cristiana Costa-Chase, Dr. Jonathan Cohen, Dr JJ Strouse, Dr Harry Erba, Dr. Mitch Horwitz
DDHM 2025
Course Directors:
Harry Erba, MD PhD
Professor of Medicine
Member of the Duke Cancer Institute
Linda Sutton, MD
Professor of Medicine
Medical Director, Duke Oncology Consortium
Member of the Duke Cancer Institute
Content Directors:
Mitch Horwitz, MD
Professor of Medicine
Affiliate of the Duke Regeneration Center
Member of the Duke Cancer Institute
Danielle Brander, MD
Associate Professor of Medicine
Member of the Duke Cancer Institute
Cristiana Costa-Chase, MD
Assistant Professor of Medicine
Member of the Duke Cancer Institute